Latest from University of Vermont Cancer Center

Immunotherapy is quickly becoming a mainstay in the frontline setting for the treatment of patients with metastatic non–small cell lung cancer.
OncLive® welcomes the University of Vermont Cancer Center to its Strategic Alliance Partnership for promoting public awareness of the latest advances in cancer research and care.
Men with a high level of cardiovascular fitness at middle age had a reduced risk of developing and dying from lung and colorectal cancer later in life.
Dr. Steven Grunberg, from the Vermont Cancer Center, Describes the 2012 Multinational Association of Supportive Care in Cancer Symposium.
Publication Bottom Border
Border Publication